Quantinno Capital Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$802K Sell
96,084
-3,040
-3% -$22K ﹤0.01% 2932
2026
Q2
$567K Buy
99,124
+50,102
+102% +$288K ﹤0.01% 2917
2026
Q1
$308K Buy
49,022
+31,518
+180% +$293K ﹤0.01% 3017
2025
Q4
$215K Buy
17,504
+3,157
+22% +$51.6K ﹤0.01% 3026
2025
Q3
$294K Buy
14,347
+1,852
+15% +$29.4K ﹤0.01% 2472
2025
Q2
$169K Buy
12,495
+476
+4% +$5.21K ﹤0.01% 2405
2025
Q1
$104K Buy
+12,019
New +$73.5K ﹤0.01% 2023

Other funds holding OPRX

Quantinno Capital Management's OPRX Position: Q3 2026 in Review

Quantinno Capital Management reduced its OptimizeRx (OPRX) stake by 3.1% in Q3 2026, selling an estimated $22K and leaving 96,084 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Quantinno Capital Management first reported a position in OPRX in Q1 2025 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • Quantinno Capital Management held 96,084 shares of OptimizeRx worth $802K as of Q3 2026.
  • Quantinno Capital Management sold 3,040 OptimizeRx shares in Q3 2026, an estimated $22K.
  • OptimizeRx made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2932 holding.
  • Quantinno Capital Management first reported a position in OptimizeRx in Q1 2025 and has held it in 7 quarters since.
  • 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.